Trulieve Q2 FY26 net loss widens to USD 406 million; revenue falls 10% to USD 271 million
Reuters2026/08/07 10:15- Trulieve Q2 2026 revenue fell 10% to USD 271 million; gross margin eased 1 percentage point to 60%.
- GAAP net loss attributable to common shareholders widened to USD 406 million, or USD 2.10 per share, including a USD 407 million Harvest deconsolidation impact.
- Non-GAAP adjusted net income turned to USD 20 million, or USD 0.11 per share; adjusted EBITDA slipped 11% to USD 98 million.
- Cash flow from operations dropped to USD 53 million; non-GAAP free cash flow declined to USD 32 million.
- Listed on the NYSE under TRLV; filed DEA registration applications after Schedule III rescheduling, began Georgia pharmacy shipments, ended Q2 with USD 325 million cash.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS lowers Ciena target price to $394
EUR/USD Price Forecast: Holds key 100-day SMA at start of the US CPI week
Malaysia Govt Spending Plan Could Help 99 Speed Mart Retail -- Market Talk
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.
